Used primarily in pharmaceutical synthesis, this compound serves as a key intermediate in the production of selective dopamine reuptake inhibitors. It is involved in the development of central nervous system agents, particularly those targeting cognitive disorders and neurodegenerative diseases. Due to its ability to cross the blood-brain barrier effectively, it enhances the bioavailability of active pharmaceutical ingredients in neurotherapeutics. Its piperidine-based structure contributes to receptor selectivity, reducing off-target effects in drug formulations.